{"address1": "Building B", "address2": "11 HaMenofim Street", "city": "Herzliya", "zip": "4672562", "country": "Israel", "phone": "972 9 799 6183", "website": "https://www.neurosense-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. Alon  Ben-Noon", "age": 45, "title": "Co-Founder, CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 660000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Or  Eisenberg", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 382000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hagit  Binder", "age": 46, "title": "Chief Operation Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 232619, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Niva  Russek-Blum Ph.D.", "age": 45, "title": "Chief Technology Officer", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 223620, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ferenc  Tracik M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 532000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yael  Barak", "age": 54, "title": "VP of Quality & Compliance", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Keren  Pushett", "title": "Head of HR", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eidan  Loushi", "title": "C.R.A.", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2053, "open": 0.1751, "dayLow": 0.1751, "dayHigh": 0.1751, "regularMarketPreviousClose": 0.2053, "regularMarketOpen": 0.1751, "regularMarketDayLow": 0.1751, "regularMarketDayHigh": 0.1751, "beta": 1.256, "volume": 648, "regularMarketVolume": 648, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.1751, "fiftyTwoWeekHigh": 0.1751, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 9693093, "bookValue": -0.142, "netIncomeToCommon": -11596000, "trailingEps": -0.935, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.1751, "recommendationKey": "none", "totalCash": 344000, "totalCashPerShare": 0.017, "ebitda": -11165250, "totalDebt": 19000, "quickRatio": 0.198, "currentRatio": 0.208, "returnOnAssets": -2.19643, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NRSNW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "marketState": "PRE", "regularMarketChangePercent": -14.710182, "regularMarketPrice": 0.1751, "shortName": "NEUROSENSE THERAPEUTICS LTD C/W", "longName": "NeuroSense Therapeutics Ltd.", "regularMarketChange": -0.030200005, "regularMarketDayRange": "0.1751 - 0.1751", "fullExchangeName": "NasdaqCM", "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.1751 - 0.1751", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "epsTrailingTwelveMonths": -0.935, "priceToBook": -1.2330985, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-09", "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_551904618", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "NeuroSense Therapeutics", "trailingPegRatio": null}